T. Rowe Price Associates, Inc. 13D and 13G filings for Utah Medical Products, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-10 2:56 pm Sale | 2022-07-31 | 13G | Utah Medical Products, Inc. UTMD | T. Rowe Price Associates, Inc. | 22,155 0.600% | -343,057 (-93.93%) | Filing |
| 2022-06-10 10:11 am Purchase | 2022-05-31 | 13G | Utah Medical Products, Inc. UTMD | T. Rowe Price Associates, Inc. | 365,212 10.000% | 22,537 (+6.58%) | Filing |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Utah Medical Products, Inc. UTMD | T. Rowe Price Associates, Inc. | 342,675 9.300% | 62,547 (+22.33%) | Filing |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | Utah Medical Products, Inc. UTMD | T. Rowe Price Associates, Inc. | 280,128 7.600% | -38,555 (-12.10%) | Filing |
| 2020-02-14 1:29 pm Purchase | 2019-12-31 | 13G | Utah Medical Products, Inc. UTMD | T. Rowe Price Associates, Inc. | 318,683 8.500% | 26,091 (+8.92%) | Filing |